Effect of CYP3A5 genotype on the relationship between hepatic CYP3A activity and CYP3A4 and CYP3A5 mRNA expression

被引：0
|
作者：
Kolwankar, D
Ho, H
Ethell, B
Vuppalanchi, R
Marri, SR
Wrighton, SA
Jones, DR
Hall, SD
机构：
[1] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA
[2] Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA
来源：
DRUG METABOLISM REVIEWS | 2004年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
237
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients
    Willrich, Maria Alice V.
    Rodrigues, Alice C.
    Cerda, Alvaro
    Genvigir, Fabiana D. V.
    Arazi, Simone S.
    Dorea, Egidio L.
    Bernik, Marcia M. S.
    Bertolami, Marcelo C.
    Faludi, Andre
    Largura, Alvaro
    Baudhuin, Linnea M.
    Bryant, Sandra C.
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    [J]. CLINICA CHIMICA ACTA, 2013, 421 : 157 - 163
  • [2] Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians
    Gebeyehu, E.
    Engidawork, E.
    Bijnsdorp, A.
    Aminy, A.
    Diczfalusy, U.
    Aklillu, E.
    [J]. PHARMACOGENOMICS JOURNAL, 2011, 11 (02): : 130 - 137
  • [3] Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians
    E Gebeyehu
    E Engidawork
    A Bijnsdorp
    A Aminy
    U Diczfalusy
    E Aklillu
    [J]. The Pharmacogenomics Journal, 2011, 11 : 130 - 137
  • [4] Analysis of genotype, MRNA and protein expression of CYP3A4 and CYP3A5 in human liver
    Czerwinski, M
    Lyon, K
    Mudra, D
    Madan, A
    van Schaik, R
    Gaedigk, A
    Parkinson, A
    [J]. DRUG METABOLISM REVIEWS, 2002, 34 : 149 - 149
  • [5] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    A. B. Sanchez Spitman
    D. J. A. R. Moes
    H. Gelderblom
    V. O. Dezentje
    J.J. Swen
    H. J. Guchelaar
    [J]. European Journal of Clinical Pharmacology, 2017, 73 : 1589 - 1598
  • [6] Statin regulation of CYP3A4 and CYP3A5 expression
    Vieira Willrich, Maria Alice
    Hirata, Mario Hiroyuki
    Crespo Hirata, Rosario Dominguez
    [J]. PHARMACOGENOMICS, 2009, 10 (06) : 1017 - 1024
  • [7] Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
    Spitman, A. B. Sanchez
    Moes, D. J. A. R.
    Gelderblom, H.
    Dezentje, V. O.
    Swen, J. J.
    Guchelaar, H. J.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1589 - 1598
  • [8] CYP3A4 and CYP3A5 genotyping by pyrosequencing
    Garsa, AA
    McLeod, HL
    Marsh, S
    [J]. BMC MEDICAL GENETICS, 2005, 6
  • [9] NEW TOOLS TO DIFFERENTIATE CYP3A4 AND CYP3A5 ACTIVITY
    Li, Xiaohai
    Kamenecka, Theodore M.
    Jeso, Valer
    Micalizio, Glen
    Heyward, Scott
    Walker, Gregory S.
    Cameron, Michael D.
    [J]. DRUG METABOLISM REVIEWS, 2015, 47 : 70 - 70
  • [10] Expression and localization of CYP3A4 and CYP3A5 in human lung
    Anttila, S
    Hukkanen, J
    Hakkola, J
    Stjernvall, T
    Beaune, P
    Edwards, RJ
    Boobis, AR
    Pelkonen, O
    Raunio, H
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (03) : 242 - 249
12345